Yong Man Kim
Directeur Technique/Scientifique/R&D chez NKGen Biotech, Inc.
Fortune : 56 200 $ au 30/04/2024
Profil
Yong Man Kim is currently the Chief Scientific Officer & Director at NKMAX Co., Ltd., the Director & Chief Scientific Officer at NKGen Biotech, Inc., and the Chief Scientific & Innovation Officer at NKGen Operating Biotech, Inc. He holds a doctorate degree from Chungnam National University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,12% | 12/02/2024 | 28 384 ( 0,12% ) | 56 200 $ | 30/04/2024 |
Postes actifs de Yong Man Kim
| Sociétés | Poste | Début |
|---|---|---|
NKGen Biotech, Inc.
 NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Directeur Technique/Scientifique/R&D | - |
NKMAX Co., Ltd.
 NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | Directeur Technique/Scientifique/R&D | 01/09/2017 |
Formation de Yong Man Kim
| Chungnam National University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Health Technology |
NKMAX Co., Ltd.
NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | Health Technology |
